Glucose metabolism during glucocorticoid treatment

Diabetologie Metabolismus Endokrinologie Vyziva

Volumn 4, Issue 4, 2001, Pages 238-248

  Vondra, K ^a   Hampl, R ^a   Starka L ^a  

^a INSTITUTE OF ENDOCRINOLOGY   (Czech Republic)

Author keywords

Diabetes mellitus; Glucocorticoids; Gluconeogenesis; Glucose tolerance; Insulin resistance

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; ACARBOSE; GLUCOCORTICOID; GLUCOCORTICOID RECEPTOR; GLUCOSE; INSULIN; METFORMIN; SULFONYLUREA DERIVATIVE;

ARTICLE; BONE METABOLISM; CHILD GROWTH; CONTROLLED STUDY; DIABETIC COMA; DIABETOGENESIS; DIET THERAPY; DOSE RESPONSE; EYE DISEASE; GENE MUTATION; GLUCOSE METABOLISM; HUMAN; IMPAIRED GLUCOSE TOLERANCE; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN RESISTANCE; METABOLIC DISORDER; NON INSULIN DEPENDENT DIABETES MELLITUS; PANCREAS ISLET; PROSPECTIVE STUDY; SEASON; TIME;

EID: 0035667368     PISSN: 12119326     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (59)

1. The antiglucocorticoid action of mifepristone
2. Effect of long-term treatment with inhaled budesonide on adult height in children with asthma
3. Endocrine-metabolic effects of asthma treatment. The impact of glucocorticoid therapy in the elderly
4. Glucocorticoids and insulin resistance: Old hormones, new targets
5. Risk factors for steroid diabetes in rheumatic patients
6. Diabetes mellitus secondary to other endocrine disorders
7. Serum glucose, C-peptide and plasma glucagon response to oral glucose after intravenous injection of different glucocorticoids at increasing doses in man
8. Case report: Amelioration of insulin resistance in diabetes with dehydroepiandrosterone
9. RU486 (MIFEPRISTONE): Mechanisms of action and clinical uses
10. Glucocorticoid receptor beta: View II
11. Inhaled and nasal corticosteroids: Factors affecting the risks of systemic adverse effects
12. Drug-induced diabetes mellitus
13. Pancreatic beta cells are important targets for the diabetogenic effects of glucocorticoids
14. Integration of some biochemical and physiologic effects of insulin that may play a role in the control of blood glucose concentration
15. Deflazacort-an alternative to prednisolone?
16. Reversal of steroid-induced insulin resistance by a nicotinic-acid derivative in man
17. Study of glucose tolerance in consecutive patients harboring incindental adrenal tumors
18. Insulin receptor/IRS-1/PI 3-kinase signaling system in corticosterodi-induced insulin resistance
19. Troglitazone efficacy in a subject with glucocorticoid-induced diabetes
20. Effects of dexamethasone on glucose-induced insulin and proinsulin release in low and high insulin responders
21. Risk and mechanism of dexamethasone-induced deterioration of glucose tolerance in non-diabetic first-degree relatives of NIDDM patients
22. A Polymorphism in the glucocorticoid receptor gene may be associated with an increased sensitivity to glucocorticoids in vivo
23. Management od diabetes during corticosteroid therapy
24. Effects of RU 486 on energy expenditure and meal tolerance in normal men
25. Effect of glucocorticoid and growth hormone treatment on proinsulin levels in humans
26. Anti-glucocorticoid effects of dehydroepiandrosterone (DHEA)
27. Adrenal suppression evaluated by a low dose adrenocorticotropin test and growth in asthmatic children treated with inhaled steroids
28. Steroidní osteoporóza
29. Effect of high-dose inhaled beclomethasone dipropionate on carbohydrate and lipid metabolism in normal subjects
30. Osteoporosis prevention, detection, treatment
31. The science and therapy of glucocorticoid-induced bone loss
32. Increased glucocorticoid sensitivity in islet beta-cells: Effects on glucose - Phosphate, glucose cycling and insulin release
33. Glucocorticoid-induced osteoporosi
34. Effects of glucocorticoids on carbohydrate metabolism
35. Predictors of change in insulin sensitivity during glucocorticoid treatment
36. Effects of troglitazone on dexamethasone-induced insulin resistance in rats
37. Acute methyprednisolone administration induces a transient alteration of glucose tolerance and pyruvate dehydrogenase in humans
38. Metabolic effects of short-term elevations of plasma cortisol are more pronounced in the evening than in the morning
39. Supression of the hypothalamic-pituitary-adrenal axis and other systemic effects of inhaled corticosteroids in asthma
40. Free fatty acif as a link in the regulation of hepatic glucose output by peripheral insulin
41. Glucocorticoid effects on bone
42. Should dehydroepiandrosterone replacement therapy be provided with glucocorticoids?
43. Alendronate for the prevention and treatment of glucocorticoid-induced osteoporosis
44. Glucose transporters and pathophysiologic states
45. Non-genomic steroid actions: Completing the puzzle. Reviews Exp Clin Endocrinol
46. Multiple sites of insulin resistence: Muscle, liver and adipose tissue
47. Zkušenosti s dlouhodobou perorální léčbou kortikosteroidy u nemocných s bronchiálním astmatem
48. Mechanisms of dexamethasone-induced insulin resistance in healthy humans
49. Peripheral glucocorticoid resistance in the light of recent knowledge of their actions
50. Long-term effects of budesonide or nedocromil in children with asthma
51. Changes in carbohydrate and lipid metabolism in children with asthma inhaling budesonide
52. Metformin příznivě ovlivnuje porušenou glykoregulaci při dlouhodobé léčbě nízkými dávkami prednisonu
53. Vztah některých steroidů, IGF-1, IGF BP-3, a růstového hormonu ke glykoregulaci při dlouhodobé léčbě nízkými dávkami glukokortikoidů
54. Glucocorticoid receptor beta: View I
55. Seasonal variation in glucocorticoid activity in healthy men
56. Dexamethasone inhibits insulin stimulated recruitment of GLUT 4 to the cell surface in rat skeletal muscle
57. The role of dehydroepiandrosterone in diabetes mellitus
58. Asthma, Steroids and growth
59. Syndromes of glucocorticoid and mineralo-corticoid resistance